Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Necrosis and FCGR3A[original query] |
---|
Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. The Journal of rheumatology 2003 Jul 30 (7): 1534-40. Tsuchiya Naoyuki, Kobayashi Shigeto, Kawasaki Aya, Kyogoku Chieko, Arimura Yoshihiro, Yoshida Masaharu, Tokunaga Katsushi, Hashimoto Hiros |
Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study. Pharmacogenetics and genomics 2006 Dec 16 (12): 911-4. Louis Edouard J, Watier Hervé E, Schreiber Stefan, Hampe Jochen, Taillard François, Olson Allan, Thorne Nicole, Zhang Hongyan, Colombel Jean-Frédér |
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Annals of the rheumatic diseases 2009 Oct 68 (10): 1547-52. Cañete J D, Suárez B, Hernández M V, Sanmartí R, Rego I, Celis R, Moll C, Pinto J A, Blanco F J, Lozano |
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-a blockers in psoriatic arthritis: a longitudinal study with 6 months of followup. The Journal of rheumatology 2012 May 39 (5): 1035-41. Ramírez Julio, Fernández-Sueiro José Luis, López-Mejías Raquel, Montilla Carlos, Arias Maite, Moll Concepción, Alsina Mercé, Sanmarti Raimon, Lozano Francisco, Cañete Juan |
Fc? receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Annals of the rheumatic diseases 2012 Jun 71 (6): 875-7. Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, Tebib J, Mariette X, Constantin |
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. Annals of the rheumatic diseases 2014 Apr 73 (4): 716-21. Quartuccio Luca, Fabris Martina, Pontarini Elena, Salvin Sara, Zabotti Alen, Benucci Maurizio, Manfredi Mariangela, Biasi Domenico, Ravagnani Viviana, Atzeni Fabiola, Sarzi-Puttini Piercarlo, Morassi Pia, Fischetti Fabio, Tomietto Paola, Bazzichi Laura, Saracco Marta, Pellerito Raffaele, Cimmino Marco, Schiavon Franco, Carraro Valeria, Semeraro Angelo, Caporali Roberto, Cavagna Lorenzo, Bortolotti Roberto, Paolazzi Giuseppe, Govoni Marcello, Bombardieri Stefano, De Vita Salvato |
Functional FCGR3A 158 V/F and IL-6 -174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis. Rheumatology international 2014 Oct 34 (10): 1409-15. Lee Young Ho, Bae Sang-Cheol, Song Gwan G |
A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF. International journal of medical sciences 2018 15 (1): 10-15. Romero-Cara Patricia, Torres-Moreno Daniel, Pedregosa José, Vílchez Juan Antonio, García-Simón María Sergia, Ruiz-Merino Guadalupe, Morán-Sanchez Senador, Conesa-Zamora Pab |
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients? Frontiers in pharmacology 2020 9 11 1207. Walczak Michal, Lykowska-Szuber Liliana, Plucinska Marianna, Stawczyk-Eder Kamila, Zakerska-Banaszak Oliwia, Eder Piotr, Krela-Kazmierczak Iwona, Michalak Michal, Zywicki Marek, Karlowski Wojciech M, Szalata Marlena, Dobrowolska Agnieszka, Slomski Ryszard, Skrzypczak-Zielinska Marze |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: